TheEdgeResearch
Home / Stocks / WLDFF

Wildflower Brands Inc. (WLDFF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$1,393
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.10
52-Wk Range
0.000001-0.00001
CEO
Stephen W. Pearce
Country
CA
Currency
USD

Wildflower Brands Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,393. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -69.9%. Its beta of -0.10 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
-2.00
Gross margin
44.6%
Operating margin
-34.2%
Net margin
-69.9%
Return on equity
Debt / equity
0.19
Current ratio
0.93
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
7
IPO date
2017-01-27
Headquarters
Vancouver, BC, CA
About Wildflower Brands Inc.

Wildflower Brands Inc. focuses on the development, design, and sale of branded cannabis goods within Washington and California. Their product line features a variety of hemp-derived CBD+ wellness items, such as topical creams, soaps, tinctures, capsules, and vaporizers. The company also offers specially curated bundle box kits. Customers can purchase these products directly through their online platform or from various retail partners. Previously known as Wildflower Marijuana Inc., the company adopted its current name, Wildflower Brands Inc., in April 2018. Its corporate headquarters are located in Vancouver, Canada.

Comparable companies

Wildflower Brands Inc. is most often compared with the following Healthcare names:

AAWHBCCOYBKUHBRIBFCBWTFCHHHFJUSHFORXOYPHCUFYOURF
More research on WLDFF
WLDFF technical analysis WLDFF TheEdge Score Compare against peers
Open full interactive analysis & DCF →